RG
CMD

Renaissance Group’s Cantel Medical Corporation CMD Stock Holding History

Renaissance Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,156
Closed -$384K – 276
2018
Q4 		$384K Sell
5,156
-111
-2% -$9.16K 0.02% 224
2018
Q3 		$485K Buy
5,267
+153
+3% +$14.6K 0.02% 234
2018
Q2 		$503K Buy
+5,114
New +$572K 0.02% 216
2018
Q1 		– Sell
-4,166
Closed -$429K – 318
2017
Q4 		$429K Buy
4,166
+43
+1% +$4.28K 0.01% 207
2017
Q3 		$388K Buy
4,123
+1
+0% +$79 0.01% 221
2017
Q2 		$321K Buy
4,122
+53
+1% +$3.98K 0.01% 250
2017
Q1 		$326K Buy
+4,069
New +$323K 0.01% 237
2016
Q4 		– Sell
-4,397
Closed -$343K – 304
2016
Q3 		$343K Buy
+4,397
New +$319K 0.01% 184

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return

Renaissance Group's CMD Position: Q1 2019 in Review

Renaissance Group sold out of Cantel Medical Corporation (CMD) in Q1 2019, closing a stake of 5,156 shares — an estimated $384K sold.

Renaissance Group first reported a position in CMD in Q3 2016 and held it in 8 quarters. The position peaked at $503K in Q2 2018. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

  • Renaissance Group reported no remaining Cantel Medical Corporation position as of Q1 2019 after selling out during the quarter.
  • Renaissance Group sold 5,156 Cantel Medical Corporation shares in Q1 2019, an estimated $384K.
  • Renaissance Group first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 8 quarters.
  • Renaissance Group's Cantel Medical Corporation position peaked at $503K in Q2 2018.
  • 254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on Renaissance Group's 13F filing for Q1 2019, filed 30 Apr 2019.